BETHLEHEM ADDIS: Open Payments
NPI 1417445107 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 11 payments from 8 companies in 2025. Trend: 2023 $848 · 2024 $513 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $217 |
| Dexcom, Inc. | 1 | $135 |
| BIOPROTECT MEDICAL, INC. | 3 | $110 |
| Astellas Pharma US Inc | 1 | $98 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
| Sage Therapeutics, LLC | 1 | $80 |
| Novartis Pharmaceuticals Corporation | 1 | $44 |
| Tempus AI, Inc | 1 | $29 |
Products named: ERLEADA, DEXCOM G7 GSS (161), BIOPROTECT BALLOON IMPLANT SYSTEM, Xtandi, VOQUEZNA, RYBREVANT, COSENTYX, XT CDX.
Industry payments across MD — which companies pay providers there.
